Clinical assessment and molecular mechanism of the upregulation of Toll-like receptor 2 (TLR2) in myocardial infarction
Mingjie Li(Shenyang Pharmaceutical University), Gang Chen(Fudan University), Hong-Bo Pan(Guangxi Medical University), Zhi‐Guang Huang(Lincoln University), Dongming Li(Dalian University), Zhen Yang, Hao Dong(China Pharmaceutical University), Shi-Bai Yan(Guangxi Medical University), Yu-Lu Tang(Guangxi Medical University), Yan-Fang Pan(Fourth Affiliated Hospital of Guangxi Medical University)
Cited by 9
Related Papers
FDA Drug Approval Summary: Gefitinib (ZD1839) (Iressa®) Tablets
|The Oncologist|2003|576
Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.
|PubMed|2002|469
Serum <scp>B</scp>‐cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survival
|British Journal of Haematology|2012|277